PrecisemAb Biotech CO., LTD.
Update：2025/12/05
Industries
Main Industry
Biotechnology
Founded Year
2021
Unified Business No.
90663465
Status
Active
Number of Employees
0
Total Paid-in
Capital
62,404,867 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PrecisemAb Biotech Co., Ltd. is a biotechnology company dedicated to developing safer and more effective antibody therapeutics through its proprietary Universal Antibody Lock technology. This innovative platform enables disease-specific activation of antibodies, reducing on-target toxicity in healthy tissues while maintaining therapeutic potency. PrecisemAb focuses on advancing next-generation biologics, including Antibody-Drug Conjugates (ADCs) and bispecific antibodies, through strategic collaborations and technology licensing to global partners.
